Pricing Log in Create free account

Annexon, Inc. (ANNX) vs Sagimet Biosciences Inc. (SGMT)

Annexon, Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. Annexon, Inc. and Sagimet Biosciences Inc. are of similar size ($802.6M and $794.3M). Across the 10 metrics below, Sagimet Biosciences Inc. leads on 8 and Annexon, Inc. on 2.

Valuation

Metric ANNX SGMT Biotechnology median
P/E n/m n/m 11.58
P/S n/m n/m 9.61
P/B 5.99 2.35 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield (24.89%) (11.30%) (32.28%)
Free cash flow yield (22.16%) (6.93%) (22.27%)

Profitability

Metric ANNX SGMT Biotechnology median
Gross margin 0.00% 0.00% 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (130.80%) (24.37%) (50.30%)
Return on assets (82.98%) (23.49%) (45.47%)
Return on invested capital 0.00% (205.24%) 0.00%

Growth

Metric ANNX SGMT Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) (32.67%) (8.97%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANNX SGMT Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 5.79 45.02 4.74
Net debt to EBITDA 1.11 1.98 1.01

Dividend

Metric ANNX SGMT Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ANNX SGMT Biotechnology median
Market cap 794.34m 802.59m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack